Ftse Mib
35.090,23
-0,64%
DAX
20.214,79
-0,51%
S&P 500
5.827,04
-1,54%
NASDAQ
19.161,63
-1,63%
Bitcoin
94.193,99
-0,31%
Pepperstone
Advertisement
Registration Strip Icon for monitor Monitora più quotazioni in tempo reale dalle principali borse, come Borsa Italiana, NASDAQ, NYSE, AMEX, Bovespa e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Ionis Pharmaceuticals Inc (IONS) Ionis Pharmaceuticals Inc (IONS) Notizie

Ionis Pharmaceuticals Inc

IONS
33,46
-0,64 (-1,88%)
11 Gen 2025 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
08/1/202522:11PRNUSIonis to present at 43rd Annual J.P. Morgan Healthcare..
06/1/202523:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/1/202522:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/1/202522:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/1/202522:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/1/202522:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/1/202522:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/1/202522:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/1/202522:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/1/202522:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/1/202522:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/12/202422:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/12/202420:28EDGAR2Form 8-K - Current report
20/12/202400:28PRNUSTRYNGOLZA™ (olezarsen) approved in U.S. as first-ever..
15/11/202402:34EDGAR2Form SC 13G/A - Statement of Beneficial Ownership by Certain..
14/11/202423:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/11/202423:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/11/202423:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/11/202414:55EDGAR2Form 144/A - Report of proposed sale of securities: [Amend]
12/11/202422:17EDGAR2Form 144 - Report of proposed sale of securities
12/11/202422:16EDGAR2Form 144 - Report of proposed sale of securities
12/11/202422:15EDGAR2Form 144 - Report of proposed sale of securities
08/11/202416:52EDGAR2Form SC 13G - Statement of Beneficial Ownership by Certain..
07/11/202413:05PRNUSIonis to present at upcoming investor conferences
06/11/202422:06EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
06/11/202417:15EDGAR2Form 8-K - Current report
06/11/202413:01PRNUSIonis Announces Pivotal Phase 3 Trial Design for ION582 in..
06/11/202413:00PRNUSIonis reports third quarter 2024 financial results
04/11/202415:44PRNUSIonis announces FDA acceptance of New Drug Application for..
23/10/202413:05PRNUSIonis to hold third quarter 2024 financial results webcast
21/10/202408:08PRNUSWAINZUA (eplontersen) recommended for approval in the EU by..
18/10/202400:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/10/202400:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/10/202413:30GLOBENew Higher Dose Nusinersen Efficacy and Safety Data..
03/10/202413:00PRNUSNew positive donidalorsen data to be presented at 2024..
02/10/202400:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/10/202413:00PRNUSZilganersen granted U.S. FDA Fast Track designation for..
10/9/202423:19EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
10/9/202403:10PRNUSIonis announces pricing of $500.3 million public offering
09/9/202422:33EDGAR2Form 8-K - Current report
09/9/202422:23EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
09/9/202422:20PRNUSIonis announces proposed public offering of common stock
05/9/202403:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/9/202403:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/9/202403:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/9/202403:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/9/202403:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/9/202403:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/9/202413:30GLOBEBiogen Announces Positive Topline Results from Study of..
04/9/202401:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
Apertura: 33,66 Min: 33,15 Max: 33,77
Chiusura: 34,10

La tua Cronologia

NASDAQ
IONS
Ionis Pharmaceuticals
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network